Finbarr E. Cotter - Concepedia

Author

Finbarr E. Cotter

Also Known As

F COTTER, F Cotter, F E Cotter, F E Cotter,, F. Cotter, F. E. COTTER, F. E. Cotter, F.E Cotter, F.E. Cotter, FINBARR COTTER

176

Publications

6.8K

Citations

H-Index

115

Concepts

All Affiliations

St Bartholomew's Hospital Queen Mary University of London Royal London Hospital University College London Institute of Cancer Research

About

Finbarr E. Cotter is an author at St Bartholomew's Hospital specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	36	3.2K
2	Health Sciences	4	4	105
3	Natural Sciences	2	2	179
4	Social Sciences	2	2	513
5	Engineering	1	1	46

Finbarr E. Cotter

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma Andrew Webb, David Cunningham, Finbarr E. Cotter, The Lancet Bcl-2 Antisense TherapyLymphoid NeoplasiaMedicineImmunologyAdult T-cell Leukemia-lymphoma	1997	498
Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma Justin S. Waters, Andrew Webb, David Cunningham, Journal of Clinical Oncology	2000	455
The 11q terminal deletion disorder: A prospective study of 110 cases Paul Grossfeld, Teresa Mattina, Zona Lai, American Journal of Medical Genetics Part A Genetic EpidemiologyDiagnosisPlatelet DysfunctionSocial SciencesPsychology	2004	343
First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trial Amy Webb, David Cunningham, Finbarr E. Cotter, European Journal of Cancer Hematological MalignancyLymphoid NeoplasiaMedicineAnti-lymphoma ActivityImmunology	1997	320
t(11;18)(q21;q21) is the most common translocation in MALT lymphomas Iwona Auer, Randy D. Gascoyne, J.M. Conners, Annals of Oncology Lymphoid NeoplasiaMedicineImmunologyHistopathologyPathology	1997	257
Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia Yie Liu, Martin Corcoran, Omid Rasool, Oncogene Lymphoid NeoplasiaChronic Lymphocytic LeukemiaMedicinePathologyTumor Suppressor	1997	217
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma Andrea Rinaldi, Ivo Kwee, Monica Taborelli, British Journal of Haematology	2005	193
Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Finbarr E. Cotter, Peter Johnson, PA Hall, PubMed	1994	186
Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways Layla J. M. Kily, Yuka C. M. Cowe, Osman Hussain, Journal of Experimental Biology Behavioral AddictionNeurotransmitterGene Expression ChangesNeurotransmissionSocial Sciences	2008	170
Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder Jürgen Groet, Suzanne McElwaine, Mônica Glória Neumann Spínelli, The Lancet Down SyndromeDevelopmental AnomalyDevelopmental BiologyGenetic DisorderMedicine	2003	167

Page 1